Gainers

• HCW Biologics (NASDAQ:HCWB) shares rose 208.8% to $1.04 during Friday's regular session. The company's market cap stands at $2.2 million. As per the news, the Q1 earnings report came out yesterday.
• P3 Health Partners (NASDAQ:PIII) stock moved upwards by 155.33% to $10.29. The company's market cap stands at $13.2 million. As per the press release, Q1 earnings came out yesterday.
• Ernexa Therapeutics (NASDAQ:ERNA) stock rose 39.59% to $13.35. The market value of their outstanding shares is at $11.1 million.
• BGM Group (NASDAQ:BGM) shares rose 31.63% to $0.39. The company's market cap stands at $59.9 million.
• XORTX Therapeutics (NASDAQ:XRTX) stock moved upwards by 24.37% to $2.5. The company's market cap stands at $3.1 million.
• Quantum Cyber (NASDAQ:QUCY) stock rose 20.67% to $3.62. The market value of their outstanding shares is at $37.5 million.

Losers

• Silexion Therapeutics (NASDAQ:SLXN) shares fell 40.9% to $0.29 during Friday's regular session. The market value of their outstanding shares is at $2.0 million.
• WORK Medical Tech Gr (NASDAQ:WOK) stock fell 39.61% to $0.79.
• Claritev (NYSE:CTEV) stock fell 35.99% to $15.03. The company's market cap stands at $400.1 million.
• Zentek (NASDAQ:ZTEK) stock decreased by 32.67% to $0.68. The market value of their outstanding shares is at $108.6 million.
• Aardvark Therapeutics (NASDAQ:AARD) stock declined by 30.39% to $4.68. The company's market cap stands at $146.8 million.
• Sunshine Biopharma (NASDAQ:SBFM) shares declined by 26.1% to $0.35. The market value of their outstanding shares is at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.